Results
Medicamen Biotech FY26 Net Profit ₹940.87 Lakhs
Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, declaring a final dividend of ₹1 per share.
Standalone net profit for FY26 was ₹940.87 lakhs, w
